View ValuationPhosAgro 将来の成長Future 基準チェック /06現在、 PhosAgroの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長20.7%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジLow最終更新日n/a今後の成長に関する最新情報Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.すべての更新を表示Recent updatesお知らせ • Mar 21Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025. Location: leninsky prospect 55 1, moscow Russiaお知らせ • Feb 17Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025.お知らせ • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024お知らせ • May 31Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024.お知らせ • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024お知らせ • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024お知らせ • Feb 23PhosAgro Global Depositary Receipts - Sponsored to be Deleted from OTC EquityPublic Joint-Stock Company PhosAgro Global Depositary Receipts - Sponsored will be deleted from OTC Equity effective February 22, 2024, due to CUSIP Suspended.Upcoming Dividend • Jul 01Upcoming dividend of ₽390 per shareEligible shareholders must have bought the stock before 08 July 2022. Payment date: 12 July 2022. Payout ratio and cash payout ratio are on the higher end at 88% and 94% respectively. Trailing yield: 11%. Lower than top quartile of Russian dividend payers (12%). Higher than average of industry peers (7.7%).Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₽4,378, the stock trades at a forward P/E ratio of 2x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 128% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₽5,452 per share.Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.Upcoming Dividend • Dec 10Upcoming dividend of ₽234 per shareEligible shareholders must have bought the stock before 17 December 2021. Payment date: 21 December 2021. Payout ratio is a comfortable 72% and this is well supported by cash flows. Trailing yield: 5.3%. Lower than top quartile of Russian dividend payers (8.2%). Higher than average of industry peers (4.0%).Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.Upcoming Dividend • Sep 16Upcoming dividend of ₽156 per shareEligible shareholders must have bought the stock before 23 September 2021. Payment date: 27 September 2021. Trailing yield: 5.9%. Lower than top quartile of Russian dividend payers (8.1%). Higher than average of industry peers (2.4%).Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.Upcoming Dividend • Jun 25Upcoming dividend of ₽105 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 06 July 2021. Trailing yield: 6.2%. Lower than top quartile of Russian dividend payers (7.7%). Higher than average of industry peers (4.1%).Upcoming Dividend • May 28Upcoming dividend of ₽63.00 per shareEligible shareholders must have bought the stock before 04 June 2021. Payment date: 08 June 2021. Trailing yield: 6.4%. Lower than top quartile of Russian dividend payers (8.0%). Higher than average of industry peers (4.3%).Reported Earnings • May 21First quarter 2021 earnings released: EPS ₽142 (vs ₽120 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₽87.6b (up 37% from 1Q 2020). Net income: ₽18.4b (up ₽33.9b from 1Q 2020). Profit margin: 21% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Feb 20Full year 2020 earnings released: EPS ₽131 (vs ₽381 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₽253.9b (up 2.3% from FY 2019). Net income: ₽16.9b (down 66% from FY 2019). Profit margin: 6.7% (down from 20% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings miss expectationsRevenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 11%. Over the next year, revenue is forecast to grow 13%, compared to a 3.2% growth forecast for the Chemicals industry in Russia.Is New 90 Day High Low • Feb 15New 90-day high: ₽3,717The company is up 21% from its price of ₽3,084 on 17 November 2020. The Russian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,498 per share.Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.Major Estimate Revision • Nov 08Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽226 to ₽249. Revenue estimate for the same period was approximately flat at ₽255.7b. Net income is expected to grow by 73% next year compared to 13% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽43.38 to ₽43.27. Share price is up 5.5% to ₽2,974 over the past week.Is New 90 Day High Low • Nov 07New 90-day high: ₽2,974The company is up 11% from its price of ₽2,680 on 07 August 2020. The Russian market is down 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽3,489 per share.Is New 90 Day High Low • Sep 28New 90-day high: ₽2,821The company is up 7.0% from its price of ₽2,643 on 30 June 2020. The Russian market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,189 per share. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、PhosAgro は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測MISX:PHOR - アナリストの将来予測と過去の財務データ ( )RUB Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2022411,81369,062N/AN/A16/30/2022580,736210,074120,592176,881N/A3/31/2022501,164175,866100,813154,138N/A12/31/2021420,488129,69777,133126,225N/A9/30/2021351,455100,82558,673103,889N/A6/30/2021306,14460,31555,983100,637N/A3/31/2021277,40050,87240,02582,083N/A12/31/2020253,87916,93241,64083,738N/A9/30/2020248,13010,64335,10377,672N/A6/30/2020241,68821,70619,61963,683N/A3/31/2020239,89612,61028,01571,085N/A12/31/2019248,12549,34928,90071,556N/A9/30/2019254,53447,16331,18371,357N/A6/30/2019252,66845,18840,48980,036N/A3/31/2019250,97736,35938,66676,745N/A12/31/2018233,31222,06921,26359,679N/A9/30/2018219,53921,83113,77552,977N/A6/30/2018203,30721,4072,63640,261N/A3/31/2018191,57519,935-2,50433,419N/A12/31/2017181,35125,333-5,92329,995N/A9/30/2017175,70832,447-6,67127,333N/A6/30/2017174,81437,50925337,086N/A3/31/2017176,06749,520-1,61038,870N/A12/31/2016187,74259,88410,11550,361N/A9/30/2016195,03953,40220,24361,867N/A6/30/2016198,54944,86014,38160,137N/A3/31/2016195,77944,905N/A65,489N/A12/31/2015189,73236,442N/A63,261N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: PHORの予測収益成長が 貯蓄率 ( 7.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: PHORの収益がRussian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: PHORの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: PHORの収益がRussian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: PHORの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: PHORの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/10/05 14:52終値2022/07/08 00:00収益2022/06/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Public Joint-Stock Company PhosAgro 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関Edwin CheeBMO Capital Markets Equity ResearchJoel JacksonBMO Capital Markets Equity ResearchSashank LankaBofA Global Research7 その他のアナリストを表示
Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.
Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.
Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.
Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.
Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.
Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.
お知らせ • Mar 21Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025. Location: leninsky prospect 55 1, moscow Russia
お知らせ • Feb 17Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025.
お知らせ • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024
お知らせ • May 31Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024.
お知らせ • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024
お知らせ • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024
お知らせ • Feb 23PhosAgro Global Depositary Receipts - Sponsored to be Deleted from OTC EquityPublic Joint-Stock Company PhosAgro Global Depositary Receipts - Sponsored will be deleted from OTC Equity effective February 22, 2024, due to CUSIP Suspended.
Upcoming Dividend • Jul 01Upcoming dividend of ₽390 per shareEligible shareholders must have bought the stock before 08 July 2022. Payment date: 12 July 2022. Payout ratio and cash payout ratio are on the higher end at 88% and 94% respectively. Trailing yield: 11%. Lower than top quartile of Russian dividend payers (12%). Higher than average of industry peers (7.7%).
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₽4,378, the stock trades at a forward P/E ratio of 2x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 128% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₽5,452 per share.
Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.
Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.
Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.
Upcoming Dividend • Dec 10Upcoming dividend of ₽234 per shareEligible shareholders must have bought the stock before 17 December 2021. Payment date: 21 December 2021. Payout ratio is a comfortable 72% and this is well supported by cash flows. Trailing yield: 5.3%. Lower than top quartile of Russian dividend payers (8.2%). Higher than average of industry peers (4.0%).
Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.
Upcoming Dividend • Sep 16Upcoming dividend of ₽156 per shareEligible shareholders must have bought the stock before 23 September 2021. Payment date: 27 September 2021. Trailing yield: 5.9%. Lower than top quartile of Russian dividend payers (8.1%). Higher than average of industry peers (2.4%).
Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.
Upcoming Dividend • Jun 25Upcoming dividend of ₽105 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 06 July 2021. Trailing yield: 6.2%. Lower than top quartile of Russian dividend payers (7.7%). Higher than average of industry peers (4.1%).
Upcoming Dividend • May 28Upcoming dividend of ₽63.00 per shareEligible shareholders must have bought the stock before 04 June 2021. Payment date: 08 June 2021. Trailing yield: 6.4%. Lower than top quartile of Russian dividend payers (8.0%). Higher than average of industry peers (4.3%).
Reported Earnings • May 21First quarter 2021 earnings released: EPS ₽142 (vs ₽120 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₽87.6b (up 37% from 1Q 2020). Net income: ₽18.4b (up ₽33.9b from 1Q 2020). Profit margin: 21% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 20Full year 2020 earnings released: EPS ₽131 (vs ₽381 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₽253.9b (up 2.3% from FY 2019). Net income: ₽16.9b (down 66% from FY 2019). Profit margin: 6.7% (down from 20% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings miss expectationsRevenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 11%. Over the next year, revenue is forecast to grow 13%, compared to a 3.2% growth forecast for the Chemicals industry in Russia.
Is New 90 Day High Low • Feb 15New 90-day high: ₽3,717The company is up 21% from its price of ₽3,084 on 17 November 2020. The Russian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,498 per share.
Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.
Major Estimate Revision • Nov 08Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽226 to ₽249. Revenue estimate for the same period was approximately flat at ₽255.7b. Net income is expected to grow by 73% next year compared to 13% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽43.38 to ₽43.27. Share price is up 5.5% to ₽2,974 over the past week.
Is New 90 Day High Low • Nov 07New 90-day high: ₽2,974The company is up 11% from its price of ₽2,680 on 07 August 2020. The Russian market is down 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽3,489 per share.
Is New 90 Day High Low • Sep 28New 90-day high: ₽2,821The company is up 7.0% from its price of ₽2,643 on 30 June 2020. The Russian market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,189 per share.